Morgan Stanley provided color on Becton Dickinson BDX after a meeting with the company's management. In a research report published today, Morgan Stanley stressed a mixed picture of strong sales growth in the developing countries and sluggish sales in the developed countries.
In the report, Morgan Stanley states, "Emerging markets are key to revenue growth, but
lackluster developed market growth may improve.
Emerging markets represent over 20% of total sales and
are growing in the low teens, driving about half of all
corporate growth. This implies developed market
growth of only 2.5-3.5%. EU safety legislation should
drive growth favorable mix, but BD may not see the
impact until the end of the of the 3 year implementation
period in late FY12 and early FY13."
At the moment, Morgan Stanley has an Equal-weight rating on the company's stock. On Monday, Becton closed the day at $87.04.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst ColorAnalyst Ratingsbecton dickinsonHealth CareHealth Care EquipmentMorgan Stanley
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in